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The paper explores the management of uncertainty, when watching the possible development 
of signs of lung cancer at a lung cancer outpatient clinic. Based on ethnographic fieldwork at a 
clinic in Denmark, it is presented how potential signs of lung cancer, termed nodules, on 
people’s lungs call to be managed due to the hope and aspirations of alleviating cancer and 
cancer related suffering. The paper suggests that the significance of the uncertainties of lung 
nodules is tried out by watching the nodule with follow-up CT-scans and opposed by focusing 
on intervention. Approaching the management of uncertainties as in a subjunctive mood, the 
paper proposes that the physicians try out a possible but indeterminate future of cancer, to 
contain the prognostic horizon and uncertainties by acting ‘as if’ cancer will develop. However, 
in this cautionary managing of cancer doubt and uncertainty, ambiguities are (re-)produced, 
leaving an interim certainty: This lung nodule is most likely not and may never become cancer.
Introduction
According to anthropologist Sharon Kaufman contemporary medicine is practi-
sed as ordinary medicine. Kaufman suggests that the desirability of disease pre-
vention and symptom control, ‘watching, waiting, testing, and treating’ (Kauf-
man 2015: 21), is taken for granted and valued as essential components of good 
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healthcare. Routine intervention as unremarkable, as well as not acknowledging 
a line of ‘too much’, is what Kaufman specifies as ordinary medicine. This kind of 
medicine is influencing us as humans to think that ‘the body is infinitely fixable 
and life is infinitely extendable’ (Kaufman 2015: 26). Kaufman furthermore descri-
bes the drive of this development in terms of how technologies of risk push our 
awareness of the risk of disease. It then becomes a moral imperative for patients 
and physicians alike to act to prevent this risk from developing into a bodily ex-
pression of disease:
“There is more risk to be aware of because technologies enable us to see and understand it 
as never before and to do so ever earlier in the course of disease […] The more risk we know 
about, the more things we can (and therefore must) do to avoid and ameliorate it” (Kaufman 
2015: 35).
Risk as a driver for action or intervention is a central theme of this paper.
As a concept, risk has been theorised in different manners in accordance with 
sociological, cultural or historical approaches. Sociologists have argued that so-
called late-modern risks and accompanying uncertainties are qualitatively and 
quantitatively different from pre-modern risks (Beck 1992; Giddens 1990). These 
new risks cannot be restricted spatially, temporally or socially, and therefore they 
cause greater reflexivity and anxiety about the contingencies of life. In opposition, 
others have argued against this notion and other illusions of modernity or empha-
sized equivalent functioning of models of misfortune and models of risk (Latour 
1994; Douglas and Wildavsky 1982). In The Taming of Chance (1990), the philosopher 
Ian Hacking tracks the genealogy of risk and the development in scientific reaso-
ning of what he terms an erosion of determinism. Hacking argues that the probabi-
listic conception of risk evolving with modernization is a radical break in styles 
of reasoning compared to earlier ways of conceptualizing misfortune. Hacking 
points to the gradual transformation in the 19th century of the understanding of 
the world as regular, but not causal. Instead of laws of nature that determine an 
outcome, we have chance and risky arguments based on probability. Probabilities 
in this sense came to tame the randomness of undesirable events, acknowledging 
the fundamental indeterminacy and irregularity of a universe of chance, but con-
struing a basis for acting (cf. Hacking 1990: 10). It is this basis for acting that I wish 
to explore further in the paper.
The paper has its empirical foundation in lung cancer diagnostics. In Denmark, 
lung cancer is the second most frequent diagnosis of cancer and the leading cause 
of cancer related death (Saghir et al. 2015). Smoking is a well-known risk factor, 
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and the incidence rates of lung cancer have risen sharply during the past sixty 
years, whereas the five-year survival-rates have remained stable around 5-10% 
(Jensen, Mainz, and Overgaard 2002). In scientific literature, chances of survival 
are strongly associated with the possibilities of curable treatments possible in the 
early stages of the disease (Saghir et al. 2015). As in other cancer settings, this is ba-
sed on a premise of ‘the sooner, the better’, as practiced in so-called early detection: 
the earlier a cancer – or a precursor to cancer – is identified, the better the survival 
odds (Cantor 2007: 2). In Denmark, cancer was reframed as an acute disease in the 
noughties and urgent referral or fast-track cancer pathways were implemented 
to ensure early diagnosis. Especially the low survival statistics when comparing 
Denmark to other Nordic countries was enhanced as an element in this reconfigu-
ration of cancer (Tørring 2014; Probst, Hussain, and Andersen 2012). With cancer 
on the political agenda, the disease continues to be prioritized financially (Sund-
heds- og Ældreministeriet 2016) and the push for early detection materialises in 
a sensitisation of technologies and bodily experiences configuring yet additional 
potential signs of cancer (Andersen 2017).
The paper analyses the management of uncertainties in practices of lung cancer 
diagnostics, as acted out when detecting “spots” or potential signs of lung cancer 
in the CT-images of patients’ lungs. The significance of a specific spot, also called 
nodule, is indeterminate: It might develop into cancer, it might be a scar after lung 
infections, it might just be there for no clear reason, and it might disappear again. 
In other words, nodules do not pose a biological risk in themselves; Only in as-
sociation with an uncertain future of potential cancer are they deemed potentially 
dangerous due to the social configuration of cancer. As a result, uncertainties both 
originates in prognostic uncertainties inherent in probabilities and uncertainties 
referring to more personal horizons of cancer-related deaths and social suffering. 
Consequently, this paper revolves around what I experienced as the main concern 
for the physicians at a lung cancer outpatient clinic (LUCA) in Aarhus, Denmark 
in the case of nodules: How to manage what we have seen on the CT-images? 
Should we follow this nodule to see how it develops or not? The practices of early 
detection as a practice for managing the uncertainties of lung cancer thus shed 
light on, but also seem to reproduce, additional uncertainties relating to the dead-
ly potential of lung nodules.
As a result, this paper adds to writings on subjunctivity (Whyte 2005) when 
exploring conditional certainty of a plan for action. In a pragmatic engagement 
with the world, the subjunctive enables practises seemingly sidestepping nodule 
uncertainties, while simultaneously exhibiting the ambiguity of nodules and the 
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continuous process of producing yet more uncertainties. As a concept, the sub-
junctive has been applied in medical anthropology in the work of Byron Good 
and Susan Whyte (Good 1994; Whyte 1997; Whyte 2005), but has also served in 
recent research on witchcraft (Bubandt 2014) and rituals (Seligman et al. 2008). In 
contrast to a voice of certainty, the subjunctive is the grammatical mood of a verb 
indicating ‘doubt, hope, will and potential’ (Whyte 2005: 251). To be acting in a 
subjunctive mood thereby denotes an experimental ‘as if’ (Seligman et al. 2008: 
7) that enables the possibility of sharing a ‘potential space of what could be’ (Se-
ligman et al. 2008: 23). Employing the idea of the subjunctive thus recognizes the 
multiplicity and inherent ambiguity of social and natural life. Before clarifying 
my analytical position, I will first give a note on methodology.
The paper is based on four months of ethnographic fieldwork at LUCA in the 
fall of 2015, interactively observing (cf. Wind 2008) physicians and nurses in their 
daily work practices as part of my thesis-project in anthropology. At LUCA I atten-
ded the daily morning-CT conferences where radiologists and physicians assessed 
the newly described CT-images of patients, the twice-weekly Multi-Disciplinary 
Team-conferences where more complex cases were assessed, as well as partici-
pating in consultations with patients by both physicians and nurses. I conducted 
semi-structured interviews (Kvale 2002) with four health professionals at LUCA 
and at least one interview with five follow-up patients in their homes. My patient-
informants did not have a face-to-face consultation at LUCA during my fieldwork. 
I have followed lung nodules through the clinic but also at a Radiological De-
partment, where I spent a day observing CT-scans and attended the CT-scans of 
three of my patient-informants. This paper primarily focuses on uncertainties of 
not-really cancer as played out in everyday clinical assessments. The paper hence 
contributes to an emerging anthropological field of ‘cancer before cancer’ (Offer-
sen 2016; Manderson 2015) to supplement the extensive focus on the perspectives 
of oncology or actual cancer patients.
Subjunctivity in nodule follow-up
Susan Whyte suggests that the contingency of the subjunctive is an aspect of ma-
naging uncertainty that situates concerns by evoking possible futures (Whyte 
2005: 254). Whyte concentrates on the Nyole setting of Uganda, where she descri-
bes how biomedicine is enacted as a distinct mode of managing uncertainty, se-
parated from the subjunctive of ritual practices (Whyte 2005: 252). In divinatory 
rituals, the possible agents behind the suffering are identified to designate a mo-
tive, a cause, and suggest a plan to straighten out a relational dispute (Whyte 1997: 
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60-83). In contrast to this, Whyte describes biomedical tests and treatments in this 
rural area as symptomatic since they do not problematize or treat the cause of 
symptoms.
In this paper, I instead explore subjunctivity in a Global North, biomedical set-
ting. I will thus argue that at the clinic of LUCA the management of lung nodules 
resonates with the Nyole ritualistic management of uncertainty in terms of sub-
junctivity. In the case of lung nodules, what a nodule signifies is uncertain and 
a question of trying out the significance through watching it. As such hope is in 
both cases, rural Uganda and urban Denmark, gathered around a concern about 
the future and the uncertainty of the outcome, but not least linked to an uncer-
tainty about aetiology (cf. Whyte 2005: 263), specifically what is the cause of this 
nodule? Will it be cancerous?
The means at hand, an algorithm recommending follow-up intervals, gives the 
conditional basis of acting, a plan to be followed, which physicians and patients in 
everyday clinical practices go along. Concurrently, the physicians concern them-
selves that their attempts at alleviating suffering might fail. Patients come to the 
physician with a hope of being told where the lung nodules come from, what is 
going to happen and where and how it ends (cf. Whyte 2005: 253): Is this cancer 
or is this not? How will this nodule affect me and the life I am leading? Instead of 
preaching firm conclusions, the diviner or physician has ‘the task of establishing 
conditional certainties’ (Ibid.: 253) by proposing a plan that is deemed reasonable 
by the patients. The physicians at LUCA simultaneously reassure patients not to 
worry and still act as if cancer could be present. In this manner, it is the evoking 
of possible futures coupled with the lack of certainty about the properties of the 
agent, the lung nodule, which epitomizes the subjunctive mood: This lung nodule 
is most likely not and may never become cancer.
This sort of managing uncertainty furthermore points towards a pragmatic 
engagement of the physicians in their clinical practices. I therefore suggest that 
the practices of nodule follow-up circle around a dialectic of knowing and not-
knowing. According to the pragmatism of John Dewey (1960 (1929)), humans fun-
damentally grapple with the world not as onlookers or spectators, but by acting 
in practice:
“If we see that knowing is not the act of an outside spectator but of a participator inside the 
natural and social scene, then the true object of knowledge resides in the consequences of 
directed action” (Dewey 1960 (1929): 196).
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Thus, the response of following nodules with CT-scans do not resolve the sur-
rounding ambiguities or uncertainties on the nature of the agent, the nodule. 
Instead, the practices inspire acting. Importantly, the configuration of nodules, 
early detection, and the related uncertainties are shaped and changed in this pro-
cess of engagement (cf. Mol 2002).
To recapitulate, the argument of the paper is that the physicians at LUCA try 
out a possible but indeterminate future of cancer through the follow-up algorithm 
by acting ‘as if’ cancer may develop. These practices at first hand shed light on, 
but then also reproduce, uncertainties relating to the perhaps deadly potential of 
nodules.
Before introducing the specific case of Mary, a patient I met at LUCA, I will 
introduce nodule assessment ‘behind the scenes’. I will describe the assessment as 
it plays out at one of the Radiological Departments of Aarhus University Hospital, 
when a person is CT-scanned, as well as how it travels through machines, persons 
and papers to the physicians at LUCA. At LUCA the physicians have consultations 
with the patients, whose CT-images initiated the flow of events.
Nodules objectified: CT-images and morning-CTs at 
LUCA
It ‘takes guts’ to close a case or keep insisting on a cancer suspicion. This is how 
some of the physicians at LUCA reflected on the practices of nodule follow-up – 
but why is it so? The assessment of follow-ups relates to the specialists’ concerns 
about balancing too much and too little intervention, about balancing the search 
for an early diagnosis with potential harm or worries for patients. Uncertainties 
abound: Issues of age, level of cancer suspicion, technological restrictions, work-
load, cases difficult to categorize, the risk of generating scanning-induced cancers 
and the limited time to settle a trajectory. All these aspects play into the diag-
nostic assessment performed at morning-CTs and in the clinic. Furthermore, the 
uncertainties of lung nodules are alleviated through acting upon it. As the phy-
sicians reflect, they do not know if this specific nodule develops or not, but they 
act upon a prospective concern of cancer by following the nodule with continuous 
CT-scanning. The physicians try to balance cancer suspicion with the possibility 
of inducing worry or discomfort for the patient. Sometimes the trajectories of the 
patients follow the regular intervals as this is seen as safer. Safe in this sense rela-
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tes to the health of the patients: The ‘damage’ of a quick CT-scan or two is incom-
parable to the prospects of lung cancer. But safer also relates to the specialists: The 
risk of overlooking an aggressive lung cancer is a responsibility and a decision too 
overwhelming for the individual specialist. As several physicians told worried 
follow-up patients, “We like to wear both belt and braces”, a way of saying that 
the physicians do not take chances and, as an institution, would rather intervene 
too much than accepting that a patient would develop an unnoticed cancer. When 
dying of cancer is essentially what is at stake, mistakes are not tolerated, as one 
physician reflected: »The procedures of CT-scanning are also sort of a safety-net 
for our sake, like ‘ohh we must not make any mistakes, so we’d better…’”.
Through fieldwork I experienced two overall bases for a CT-scan of the lungs, 
what physicians refer to as the indication: 1) The patient had consulted her gene-
ral practitioner (GP) on a bodily concern, who on the basis of their conversation 
would refer the patient to the hospital for a CT-scan because of possible signs of 
lung cancer. 2) The patient had been referred directly from another hospital de-
partment; Here the physicians, while examining for something else, for instance 
when performing a CT-scan focussing on the heart, would have detected possible 
pathological changes in the lungs. When the patient’s lungs have been scanned, 
a physician specialized in chest radiology, a radiologist, assesses the images. The 
radiologist writes a short summative description following a template distin-
guishing several key issues of relevance for deciding a trajectory. The descrip-
tion is written in a passive voice indicating that whoever would assess the images 
would reach similar findings and conclusions. Like Timmermans and Berg argue 
(2003), you cannot see the individual and messy steps of interpreting the ima-
ges. The final description instead leaves the impression of a true description (cf. 
Timmermans and Berg 2003: 66) that can travel unchanged from the Radiological 
Department to LUCA.
All new case-descriptions related to the lung cancer fast-track are run through 
at the daily morning-CT conferences, where a radiologist and a lung specialist 
from LUCA, one of the senior physicians, attend. Usually, the radiologist prepares 
the conference beforehand by getting the patients’ images on the large screens 
hanging on the wall. The morning-CT lasts less than 30 minutes with the ima-
ges of between 15-20 patients and possibly some extras not on the list being run 
through. The tempo of the conference is up-speed, leaving time only for a brief 
presentation of the patient-case, where the radiologist mostly indicates the pre-
ferred trajectory. In relation to lung nodules, there would be the overall decision 
on whether to propose a follow-up or not, and in case of a follow-up to settle 
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on the time interval to the next follow-up based on the international Fleischner-
algorithm (DLCG 2014: 12): 
All new case-descriptions related to the lung cancer fast-track are run through 
at the daily morning-CT conferences, where a radiologist and a lung specialist 
from LUCA, one of the senior physicians, attend. Usually, the radiologist prepares 
the conference beforehand by getting the patients’ images on the large screens 
hanging on the wall. The morning-CT lasts less than 30 minutes with the ima-
ges of between 15-20 patients and possibly some extras not on the list being run 
through. The tempo of the conference is up-speed, leaving time only for a brief 
presentation of the patient-case, where the radiologist mostly indicates the pre-
ferred trajectory. In relation to lung nodules, there would be the overall decision 
on whether to propose a follow-up or not, and in case of a follow-up to settle 
on the time interval to the next follow-up based on the international Fleischner-
algorithm (DLCG 2014: 12):
The consensus-based algorithm is also a means to limit the time spend on each 
individual case as the follow-up interval directly follows from the size of the no-
dule and the risk-status of the patient. As seen in the algorithm, nodules only 
have visual properties: you cannot biopsy, feel or smell a nodule – only see it in 
CT-images. Its biological properties are indeterminate. Nodules are thus a product 
of ever more fine-tuned imaging technologies and the dilemma of cancer in a set-
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ting of early detection. Nodules would not materialise if this setting was different. 
This sort of scientific phenomena can be described as techno-phenomena, as defined 
by Allan Young as products of ‘technologies, practices, and preconditioned ways 
of seeing’ (Young 1995: 10).
At a morning-CT in October 2015, prompted by my description of my fieldwork 
project, Nicole, the radiologist, tells about her recent study-visit to the US and 
the lung cancer screening trials they are conducting ‘over there’. She describes 
how the specialists re-scan participants above the age of 55 every five years if the 
screening participants have an empty scan without “significant alterations”. Ni-
cole then adds with a smile: “But as a smoker above the age of 55, nobody has an 
empty scan!” As presented by Nicole, nodules in older smokers are thus in terms 
of frequency comprehended as normal. A recent Danish trial on symptomatic pa-
tients showed that a nodule was identified in 22.7% of the conducted CT-scans 
(Guldbrandt et al. 2014). This implies normality as that within the statistical norm 
or average (cf. Hacking 1990: 107-108), regularly occurring, but still treated as po-
tentially pathological and in need of being watched.
At a morning-CT in November the images of patient no. 17 on the list is up on 
the screen. While Catherine, a senior lung specialist, writes the plan for the pa-
tient, Nicole, the radiologist, starts typing the personal identification number of 
the next patient into the computer. The CT-images of the next patient appear on 
the screens. This is now patient no. 18:
Nicole: “Previously pneumonia times two. This also looks like a classic pneumonia”. 
Catherine: “Well, I’ll take her in for a bronchoscopy – and see if we can find something”.
Before I have finished scrambling my notes, the next patient is already up on the 
screen and the radiologist almost done presenting the case:
Nicole: “Ex-smoker, NB c. pulm. [cancer, pulmonary]. There’s a 5.5 mm [lung nodule]”. 
Catherine, while noting the interval on the description: “So, follow-up in six months”.
As represented, the run-through is brief and focused, based on objectified forms 
of knowledge and mostly reporting what has already been indicated by the ra-
diologist describing the CT images. Still, it is the voice of the subjunctive which 
provides the basis of acting: “it looks like” pneumonia and we’ll “see if we can 
find something”. In the case of nodules, the radiologist notes the patient as at risk 
or not, for instance if the patient is a smoker or ex-smoker with an extensive smo-
king history. She then notes the size of the nodule as well as the recommended 
plan sometimes supplemented by the lung specialist voicing the exact follow-up 
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interval. Immediately, this left me with the impression that the assessment of no-
dules is a straightforward evaluation: Risk patient + 5.5 mm nodule --> Follow-up 
in six months. And indeed, many of the assessments of patient-cases follow the 
standard template. However, behind this template is a case of negotiating various 
modes of uncertainty, for instance age, but also, as I will show, the size of the no-
dule, and the patients’ smoking history. All of this speaks to establishing a shared 
level of cancer suspicion. In this sense, an answer to the basic prognostic uncer-
tainty of lung nodules is sidestepped to be reassessed later; or rather the answer 
for the physicians is to subjunctively try out a specific potential future of cancer 
or not cancer through the algorithm. To unfold the aspect of subjunctivity, I will 
now introduce Mary, an elderly woman at the age of 66 years. Through this ethno-
graphic story, I will illustrate how a subjunctive mood counters uncertainties by 
focusing on action.
Negotiating the significance of a nodule: The case of 
Mary
I meet Mary the first time in the form of the CT-images of her lungs at a morning-
CT in September 2015. Mary has undergone a scan of her heart and in those ima-
ges the cardiologists have noticed a small, denser area and measured this nodule-
area as being 13 mm. Mary has therefore been referred to LUCA and to a CT-scan 
of her lungs in order to clarify whether there is a need for further examinations. In 
this additional scan the nodule is now measured to a size just under one cm and 
the radiologist adds that “you can’t do anything now”, meaning that the nodule 
is too small to be biopsied, but implying an inclination of doing something. The 
radiologist therefore recommends a follow-up scan in three months as per the 
algorithm.
Mary has been called for a consultation at LUCA the same day. Before the con-
sultation, the physician Sarah summarizes the basis for the referral of Mary to a 
medical student, who, besides Sarah and I, will also attend the consultation:
“The patient has been smoking for a long time. She has undergone a heart-CT on the indi-
cation of chest pains, so this nodule is what we call an incidental finding, since originally it 
was something else she was being examined for.”
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Sarah describes to the medical student that the follow-up interval of a small no-
dule especially depends on whether the patient is a smoker, which Mary is. She 
then adds: “She [Mary] has probably been telephoned and told that something has been 
detected – so she is most likely a bit worried”.
At the consultation Mary has brought her husband, who sits quietly throughout 
the session. In the call for the appointment, patients are encouraged to bring rela-
tives for the consultation, and the vast majority of patients bring somebody with 
them. Sarah, who has not met Mary before, begins the conversation by recounting 
the basis of Mary’s referral and how her trajectory has been this far, to ensure a 
common ground for the conversation. At other consultations, the patient herself 
was encouraged to retell the story.
Sarah: “As you know, a small spot of about 13 mm was initially detected, and this is why 
we afterwards scanned the entire lung. Here, we didn’t find anything else than the small spot 
and we then measured the spot to about 9 mm”.
Mary interrupts: “You see, I also have middle lobe syndrome [chronically collapsed lung 
tissue in the middle lobe] and is attended to by a private specialist – could that have so-
mething to do with all this?”
Sarah: “No, the middle lobe looks fine. And we’re not worried about this spot either. Many 
people have this kind of spot. But we would like to follow it and see if it gets smaller, stays as 
it is or perhaps grows in size”.
Mary continues presenting her ‘medical history’ and describes a recent lung infec-
tion. She also tells about her use of a PEP-flutter device to help her get rid of mucus 
in her lungs. Sarah asks about Mary’s use of the flutter and advices her to be more 
diligent with it. Sarah then wraps up the conversation by summarizing what the 
next step is, namely that “we would like to see you again in a three months’ time for a 
follow-up”. However, Mary is not quite finished with the indeterminate spot on her 
lung: “But” Mary hesitates, “What can it be?” Sarah therefore returns to the spot 
and emphasizes that it “can be anything” and that spots like these “are often seen in 
smokers a little advanced in years”. Mary sighs. She is somewhat reassured by the 
descriptions of nodules in smokers as normal, even though normality in this sense 
does not definitively exclude the potential of cancer. Nevertheless, Mary exclaims: 
“What a relief! I have been really nervous!” On her way out, instead of shaking hands, 
Mary gives all three of us a hug.
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I have chosen this ethnographic snippet of a consultation to illustrate how 
uncertainties on the properties of the nodules are practiced in collaboration with 
patients, and how a subjunctive mood counters uncertainties by situating the fu-
ture through action. Initially, Sarah is focused on describing the characteristics 
of the nodule, especially the size of the nodule. For Sarah it is important that the 
nodule is re-measured to be below one cm as this serves as the limit of considering 
to biopsy. For Mary, the difference between 13 mm and 9 mm remains unexpla-
ined, only implying that smaller is better. Furthermore, Sarah describes how the 
detection of the nodule relates to cancer, in this case that “we didn’t find anything 
else” and “we’re not worried”. Also in morning-CTs, the relation to cancer, termed 
malignancy, was a central reference point resulting in the often used term of “non-
malignancy-suspicious” [ikke malignitetssuspekt]. Then, when Mary interrupts 
with her more broadly related concerns regarding her lungs, Sarah plays along on 
this shift of attention. As a result, the properties of the spot stay at the side-line. 
For Sarah, the next important step is the question of what the plan should be, how 
to act from here. For Mary this leads back to the questions of what this nodule 
actually is. At the morning-CT the uncertainties of the cancerous potential of the 
nodule were circumscribed by the fact that the nodule is too small to be biopsied. 
At the consultation, Sarah furthermore plays down the potential of cancer, but she 
still maintains the uncertainty of outcome.
For patients like Mary, it is not the prognostic uncertainties of nodules that are 
at stake: It is not about questioning the basis for the evaluation of nodules or que-
stioning the probabilistic uncertainties of being afflicted by cancer. In scientific 
literature, these uncertainties do create debate (cf. Hillerdal 2008; Harzheim et al. 
2015). Instead, the ambiguous potential of cancer related suffering lurks more or 
less openly in the shadows. For the physicians at LUCA, such as Sarah, it is the 
uncertainties of too much or too little which seem most relevant. Together these 
uncertainties form the basis of what I below describe as a cautionary management 
that reproduce nodule uncertainties.
Reproducing and moulding uncertainties of the 
potential of cancer
In patient consultations, like in the consultation with Mary, I heard various de-
scriptions of nodules such as “we [the physicians] are not that worried, but we want 
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to keep track of it [the nodule] to see that it doesn’t develop” and “At your age and as a 
smoker, we see this in many lungs”. I also overheard the nurses when they answered 
telephone calls from puzzled follow-up patients. In a specific situation, the nurse 
Michelle described the nodules as “presumably scar-tissue”, and “two small spots that 
we want to keep an eye on” since you “can never be a hundred percent sure” what it is. 
She then explained that the patient “should expect that we want to follow you for up 
to two years. If it then remains unchanged, at that point we dare to say that it’s nothing”.
As illustrated in Michelle’s explanations and in Sarah’s conversation with Mary, 
both the practices of managing nodule uncertainties through the algorithm and 
describing nodules to patients are loaded with conditionality and uncertainties of 
the potential of cancer. The practices give the simultaneous impression of risk – 
since we need to watch this and act early in case of cancer – and safety – because 
the health professionals assure the patient that she is not to worry, nodules are 
quite ordinary. When I asked specifically, the senior lung physicians reflected on 
the procedures of managing lung nodules. In an interview, Amy describes it in 
this manner:
“I think they [the follow-ups] are demanding in time, and that is both for the Radiological 
Department and for us [in LUCA]. And then I think, in some way, that it’s a bit of a diffuse 
thing to impose on people that, well there is something which is 8 mm big, so we need to 
keep an eye on that”. Amy pauses in her sentence, “If we could only tell people that we know 
this won’t develop, but we don’t dare”. Amy pauses a bit and then concludes, “That’s why I 
actually find this a bit difficult”.
As illustrated with Amy, the physicians might feel personally ambivalent about 
the follow-up regimen, but they cannot see any other way to handle the nodules 
when keeping within an institutionalised setting of early detection. As such, the 
physicians need to manage the existential uncertainties of patients fearing cancer 
and balance this with a setting enrolled in action and a general feeling of nearing 
the limits in terms of capacity, not least due to demands of efficiency (cf. Andersen 
and Vedsted 2015). With the focus on early detection of cancer, GPs have been 
encouraged to refer patients directly to a CT-scan when the GP has a suspicion of 
lung cancer. This direct-CT pathway was implemented in the area of Aarhus in 
2014 (Guldbrandt 2014), and the opportunity tremendously increased the number 
of performed CT-scans and thus the number of established lung nodules. When 
interviewing Amy, she reflected on the attitude of trying to limit workload in re-
lation to the criteria of follow-up:
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“Well, personally I would also say, ’Well then scan me’, if it was me. But I think it is a lot of 
bother for something which sometimes has been found entirely by accident…We are always 
happy if we discover that the patient has an older CT-scan where this thing [the nodule] was 
also present. Then we can close the case right away“.
If a nodule is present at an earlier CT-scan, then the follow-up interval starts at that 
point. Is the scan older than two years, then the physicians at LUCA will argue 
closing the case when considering their degree of cancer suspicion. These sorts of 
considerations of time and workload are also reflected in several comments from 
the radiologists and lung specialists at different morning-CTs. Here the specia-
lists negotiate the interpretation of nodule size and belief of cancer to try to limit 
follow-ups; the smaller the nodule, the longer the interval for a follow-up, with 
specific tipping-points as seen in the algorithm:
Lung specialist: ”Could we squeeze it [the measurement of the lung nodule] just below 6 
mm?”,
Radiologist: “I’d rather say that the nodules are less than 4 mm”,
Lung specialist: “Could we say six months [instead of three]?”,
Radiologist: “All the nodules are calcified, so there isn’t as such a reason to follow him – We 
don’t have to place everybody in a follow-up regimen”.
In the above ethnographic excerpts, we furthermore see how the physicians try 
out the meaning of images through practice in what can be termed a pragmatic 
engagement with the world. The physicians use tools, theories, and technologies 
in a dialectic process of knowing and not-knowing, when assessing the potentials 
of lung nodules. Some of these assessments vary between the different specia-
lists, for instance based on their confidence in the field and their attitude towards 
overdiagnosis. Deciding a trajectory is furthermore connected to the interplay 
between the specialists at the specific morning-CT. One particular senior radiolo-
gist often alluded to the differences between principles and practice, for instance 
when mentioning uncertainties in image technology by stating: “It is not uncom-
mon that PET will light up without a [cancerous] basis for it”, or by commenting on 
decisions not strictly adhering to guidelines: “Has it just become routine to follow-up 
without knowing what happens in the rest of the body?” At that morning-CT, the radio-
logist tried to take the discussion with the lung specialist and the other radiologist 
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who were present, “If we don’t do this [PET-scan], we might as well choose to overlook 
this nodule as well – there are more than one way to make mistakes, you know”. But in this 
case, nobody answered and the conference continued with the next patient-case.
The proposition to overlook something is interesting in terms of what seeing im-
plies in nodule and cancer diagnostics. A nodule exists because it is technolo-
gically manifested through a CT-scan – it does not produce bodily signs in the 
patients beforehand. On the basis of the algorithm, the radiologists and the lung 
specialists together oversee, that is keep an eye on, the potential development of 
a nodule. To overlook then puts the foundation for the follow-up regimen at stake. 
Thus, if something is established or made visual via image technologies, the phy-
sician needs to act, and the preferred action for nodules is the so-called watchful 
waiting of follow-ups (Wiener et al. 2015). This implies a strong inclination toward 
follow-ups, regardless that for instance nodules are comprehended as ordinary 
for the majority of patients, as was illustrated by the comment of Nicole. In an in-
termittent lunch break, I interviewed a physician, Jennifer, who clearly articulated 
the aspect of seeing:
“Well, we find a lot of these small thingies, as you say, that you wouldn’t have been able to 
see in an ordinary x-ray, but when you’ve seen them, then you have to follow up on it, and 
you also know that a small percentage of these nodules start to grow, and that it is some sort 
of precancerous lesion. Ehh, so I think ehh, that we have quite many of these [lung nodules], 
and we perform many CT-scans on that basis, but, necessarily, it has to be that way now 
that we have seen it.”
In other words, the nodule is absent until it is seen. The nodule is a techno-phen-
omenon in the sense that it is not a pre-existing object with inherent properties 
but come into being in specific coordinating configurations. It furthermore seems 
that when trying to control cancer yet earlier expressions of potential cancer risk 
materialise. In this specific case through the detection of lung nodules but similar 
examples are found in other types of cancer such as bladder polyps and cell chan-
ges of the breasts or cervix (van Rhijn et al. 2009; Mannu et al. 2015; Thomsen et 
al. 2016). Thus, cancer as an indeterminable threat is reproduced at the molecular 
level. The fear and threat of cancer is in the case of nodules conflated with the 
disease (cf. Aronowitz 2009), yet the disease – cancer – and the possible expression 
of it – the nodule – is bodily absent from daily experiences of patients: the few 
millimetres big nodule in the lungs of patients does not produce bodily signs that 
can possibly be recognized.
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Concluding remarks
When cancer disease control is framed through practices and ideals of early detec-
tion, uncertainties of cancer risk are produced and reconfigured. At an institutio-
nal level, through the logics of probability these uncertainties are managed. At the 
specific level of physicians in a clinical setting, the response of following nodules 
with CT-scans develops when trying to balance the prognostic uncertainties of 
nodules – is this a sign of cancer? – with the prospects of doing too much or too 
little – either imposing diagnostics on ‘healthy’ patients or overlooking a cancer. 
Follow-ups do not resolve these uncertainties, for neither the physicians nor the 
patients; we still do not know whether a specific nodule is cancerous. However, 
they lay a course of action with the aim of a provisional certainty. I have therefore 
argued that this precautionary plan of watching nodules is an act in the subjunc-
tive mood establishing conditional certainties: This lung nodule is most likely not 
and may never become cancer. 
Consequently, the management of lung nodules exhibits the uncertainties and 
heterogeneities of cancer biology in terms of questioning who will be affected 
and how severe. It is about qualifying degrees of cancer suspicion in a cautionary 
concern with the future. Thus, approaching the practices of lung nodule diagno-
stics through inspiration from Whyte and her notion of the subjunctive highlights 
how the physicians act as if cancer is present with the hope of being able to act 
‘in time’ before death is irreversible. Additionally, to include the notion of a prag-
matic engagement is a manner of highlighting diagnostic decisions as configured 
in practices of grappling with uncertainty. Thus, biomedical practises of mana-
ging risk and uncertainty ambiguously act out potential scenarios. Consequently, 
uncertainties are not easily resolvable. They are instead reconfigured and produ-
ced in the processes of managing them. The different uncertainties of cancer thus 
migrate to the molecular level of nodules materialising in yet new formations of 
cancer risk.
As suggested in the introduction, the ordinary in medicine has become to 
watch and intervene without being able to see where to draw the line. The prac-
tices of lung cancer diagnostics teach us that the physicians at the outpatient cli-
nic interacting with patients every day very much acknowledge the ambiguities 
and uncertainties of medical practice. However, “doubt is blocked institutionally” 
(Douglas 2001: 145) through guidelines, regulation, and pressures of efficiency. To 
deal with contemporary uncertainty instead seems to demand a general acknow-
ledgement of uncertainty as the norm. To do this, practitioners of medicine need a 
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space to take up the inherent ambiguities of medical diagnostics and treatment in 
dialogue with patients to be able to suggest that there are other ways to go around 
these issues.
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